Abstract
The groundbreaking discovery that pluripotency can be induced in somatic cells opened new fields in sciences. Generation of patient- and disease-specific cell lines for drug screening and medical research is in reach. However, the numerous possibilities are limited by the amount of cells needed, that cannot be supplied by state-of-the-art cultivation techniques. New approaches for cell culture automation are wanted, mapping the requirements for this interesting, yet sophisticated cell type.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Literatur
Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147
Gurdon JB (1962) The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10:622–640
Itzhaki I, Maizels L, Huber I et al. (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471:225–229
Tabar V, Tomishima M, Panagiotakos G et al. (2008) Therapeutic cloning in individual parkinsonian mice. Nat Med 14:379–381
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481:295–305
Das AK, Pal R (2010) Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications. J Tissue Eng Regen Med 4:413–421
Shafa M, Sjonnesen K, Yamashita A et al. (2012) Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med 6:462–472
Schutz A, Koch S, Fuss M et al. (2012) An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trails. PLoS One 7:e51715
Schulz JC, Stumpf PS, Katsen-Globa A et al. (2012) First steps towards the successful surface-based cultivation of human embryonic stem cells in hanging drop systems. Eng Life Sci 12:584–587
Boheler KR, Czyz J, Tweedie D et al. (2002) Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91:189–201
Pera MF (2011) Stem cells: the dark side of induced pluripotency. Nature 471:46–47
Author information
Authors and Affiliations
Corresponding author
Additional information
Ina Meiser 2001–2005 Bachelorstudium der Bioinformatik an der Universität des Saarlandes. 2005–2007 Masterstudium der Biotechnologie an der Universität des Saarlandes. Seit 2008 Doktorandin am Fraunhofer-Institut für Biomedizinische Technik, St. Ingbert.
Isabelle Sébastien 2002–2004 Diplôme Universitaire de Technologie an der Universität Joseph Fourier, Grenoble, Frankreich. 2004–2006 Ingenieurstudium des Chemieingenieurwesens an der Fachhochschule Münster, Steinfurt. 2006–2008 Masterstudium der Biotechnologie an der Universität des Saarlandes. 2009–2011 Bio-Ingenieurin am Helmholtz-Zentrum Geesthacht. Seit 2012 wissenschaftliche Mitarbeiterin am Fraunhofer-Institut für Biomedizinische Technik, St. Ingbert.
Julia C. Neubauer 2001–2006 Biologiestudium an der Universität Würzburg. 2007–2012 Promotion (Dr. rer. nat.) am Fraunhofer-Institut für Biomedizinische Technik, dort seit 2012 Leiterin der Arbeitsgruppe „Zellkultur-Automatisierung“.
Rights and permissions
About this article
Cite this article
Meiser, I., Sébastien, I. & Neubauer, J.C. Automatisierte Kultivierung von induziert pluripotenten Stammzellen. Biospektrum 19, 523–526 (2013). https://doi.org/10.1007/s12268-013-0351-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-013-0351-8